117976-90-6: Rabeprazole Sodium STAGE – I
Rabeprazole Sodium STAGE – I (CAS No: 117976-90-6) or 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole, Sodium Salt, is a proton pump inhibitor and is an antiulcer drug that used to treat gastrointestinal ulcers heal and to treat symptoms of gastroesophageal reflux disease (GERD).
Additional information on CAS 117976-90-6
Catalogue No.
VL970002
CAS No.
117976-90-6
Molecular Formula
C18H20N3NaO3S
Molecular Weight
381.4
Parent drug
Rabeprazole
IUPAC Name
2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole, Sodium Salt
Synonyms
Rabeprazole Sodium Salt
References
Prakash, Amitabh, and Diana Faulds. “Rabeprazole.” Drugs, vol. 55, no. 2, 1998, pp. 261–67, https://doi.org/10.2165/00003495-199855020-00009. ?
Status
Not Available
Other products related to rabeprazole
Name of Impurity | Catalogue No. |
---|